Publicaciones
-
Cubiró X, Garcia-Melendo C, Morales-Munera CE, Roé-Crespo E, Riera-Mestre A, Mora-Luján JM, Iriarte A, Puig L and Baselga E.
Satisfactory treatment of mucocutaneous lesions in hereditary hemorrhagic telangiectasia patients with dual pulsed dye laser and neodymium: yttrium-aluminum-garnet
DERMATOLOGIC THERAPY . 34(6): . Nº de citas: 3
-
Puttgen, KB, Hansen, LM, Lauren, C, Stefanko, N, Mathes, E, Olsen, GM, Tollefson, MM, Adams, D, Baselga E, Chamlin, S, Corey, K, Frascari, FF, Frieden, IJ, Galligan, ER, Gupta, D, Haggstrom, A, Horii, K, Hornik, CP, Klajn, J, Liberman, L, Mancini, A, Mannschreck, D, McGinness, A, McCuaig, C, Newell, B, Nguyen, H, Nopper, A, Oyesanya, T, Powell, J, Reynolds, M, Rios, M, Siegel, DH, Ward, K, Garzon, MC, Frommelt, P and Drolet, BA.
Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY . 85(2): 345-352. Nº de citas: 17
-
Muñoz-Garza FZ, Ríos M, Roé-Crespo E, Bernabeu-Wittel J, Montserrat-García MT, Puig L, Gich I and Baselga E.
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage A Randomized Clinical Trial
JAMA DERMATOLOGY . 157(5): 583-587. Nº de citas: 32
-
Rössler J, Baselga E, Davila V, Celis-Passini V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM and Kapp FG.
Severe adverse events during sirolimus "off-label" therapy for vascular anomalies
PEDIATRIC BLOOD & CANCER . 68(8): . Nº de citas: 30
-
López-Sánchez C, Falla LM, Roé-Crespo E, Arostegui-Gorospe JI, Mozos A, Bernal S, Iznardo H and Baselga E.
Excellent response to secukinumab in an infant with severe generalized pustular psoriasis
JOURNAL OF DERMATOLOGY . 48(6): 907-910. Nº de citas: 12
-
Galligan ER, Baselga E, Frieden IJ, Kittler NW, Lauren CT, Morel KD, McCuaig C, Pope E, Tollefson M, Tantuco K, Wargon O and Garzon MC.
Characterization of vascular stains associated with high flow
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY . 84(3): 654-660. Nº de citas: 8
-
Dávila Osorio VL, Vicente-Villa MA, Baselga E, Salvador-Hernandez H, Cruz-Martínez O and Prat-Torres CS.
Adverse cutaneous effects of mitogen-activated protein kinase inhibitors in children
PEDIATRIC DERMATOLOGY . 38(2): 420-423. Nº de citas: 8
-
Valdivielso-Ramos, M, Martin-Santiago, A, Azana, JM, Hernandez-Nunez, A, Vera, A, Perez, B, Tercedor, J, Feito, M, Vicente-Villa MA, Prat-Torres CS, Lopez-Gutierrez, JC, Garnacho, G, Baselga E, Roe, E, Palencia, S, Cordero, P, Moreno, R, Agudo, A, de la Cueva, P and Torrelo, A.
Capillary malformation-arteriovenous malformation syndrome: a multicentre study
CLINICAL AND EXPERIMENTAL DERMATOLOGY . 46(2): 300-305. Nº de citas: 28
-
Iznardo H, Baselga E, Mozos A, Szafranska J, Orellana-Fernández R and Roé E.
Net-like superficial lymphatic malformation
PEDIATRIC DERMATOLOGY . 38(2): 516-517. Nº de citas: 2
-
Diociaiuti A, Carnevale C, Baselga E, Léauté-Labrèze C, Neri I, Rotunno R, Figà-Talamanca L and El Hachem M.
Cutaneous Infantile Haemangiomas with Intracranial and Intraspinal Involvement: A European Multicentre Experience and Review
ACTA DERMATO-VENEREOLOGICA . 100: . Nº de citas: 5